CareCentric Announces Filing of Deregistration with

Securities and Exchange Commission

ATLANTA, GA (September 8, 2003) - CareCentric, Inc., (OTCBB: CURA) a leading provider of management information systems to the home health care community, announced today that it has filed a Form 15 with the Securities and Exchange Commission to cease reporting as a public company because it has less than 300 stockholders as a result of its merger on September 4, 2003 with an investor group (Borden Associates, Inc.) led by its major stockholder, John Reed, and his son, Stewart Reed. In addition, CareCentric’s common stock will no longer be eligible for quotation on the OTC Bulletin Board. The Company expects its common stock will cease being quoted on OTC by September 10, 2003.

CareCentric provides information technology systems and services to over 1,500 customers. CareCentric provides freestanding, hospital-based and multi-office home health care providers (including skilled nursing, private duty, home medical equipment and supplies, IV pharmacy and hospice) complete information solutions that enable these home care operations to generate and utilize comprehensive and integrated financial, operational and clinical information. With offices nationwide, CareCentric is headquartered in Atlanta, Georgia.

Note regarding Private Securities Litigation Reform Act: Statements made in this press release which are not historical facts, including projections, statements of plans, objectives, expectations, or future economic performance, are forward looking statements that involve risks and uncertainties and are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. CareCentric's future financial performance could differ significantly from that set forth herein, and from the expectations of management. Important factors that could cause CareCentric's financial performance to differ materially from past results and from those expressed in any forward looking statements include, without limitation, the inability to obtain additional capital resources, variability in quarterly operating results, customer concentration, product performance and acceptance, long sales cycles, long and varying delivery cycles, CareCentric's dependence on business partners, emerging technological standards, risks associated with acquisitions and the risk factors detailed in CareCentric's Registration Statement on Form S-4 (File No. 333-96529) and from time to time in CareCentric's periodic reports filed with the Securities and Exchange Commission. In addition, the merger transaction may not achieve the degree of significant expense savings and other benefits anticipated by CareCentric. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.